2021
Risk reduction and pharmacological strategies to prevent progression of aortic aneurysms
Weininger G, Chan SM, Zafar M, Ziganshin BA, Elefteriades JA. Risk reduction and pharmacological strategies to prevent progression of aortic aneurysms. Expert Review Of Cardiovascular Therapy 2021, 19: 619-631. PMID: 34102944, DOI: 10.1080/14779072.2021.1940958.Peer-Reviewed Original ResearchConceptsAortic aneurysmAbdominal aortic aneurysmß-blockersAngiotensin II receptor blockersAngiotensin-converting enzyme inhibitorAnti-platelet medicationDifferent pharmacologic therapiesII receptor blockersAortic aneurysm patientsThoracic aortic aneurysmRisk reductionAortic aneurysm growthPharmacologic managementReceptor blockersPharmacologic therapyMedical therapySurgical interventionAneurysm patientsMiscellaneous drugsAneurysm diseasePharmacological strategiesSyndrome patientsMarfan syndromeEnzyme inhibitorsAneurysms
2019
Simple renal cysts and bovine aortic arch: markers for aortic disease
Brownstein AJ, Bin Mahmood SU, Saeyeldin A, Velasquez Mejia C, Zafar MA, Li Y, Rizzo JA, Dahl NK, Erben Y, Ziganshin BA, Elefteriades JA. Simple renal cysts and bovine aortic arch: markers for aortic disease. Open Heart 2019, 6: e000862. PMID: 30774963, PMCID: PMC6350752, DOI: 10.1136/openhrt-2018-000862.Peer-Reviewed Original ResearchBovine aortic archSimple renal cystsThoracic aortic diseaseAbdominal aortic aneurysmType B aortic dissectionB aortic dissectionAortic dissectionAortic aneurysmAortic diseaseAortic archRenal cystsChronic kidney diseasePresence of hypertensionAortic aneurysm developmentAbdominal CTMultivariable analysisKidney diseaseRetrospective searchPatientsAneurysm developmentAneurysmsPropensity scoreDiseaseDissectionPrevalence
2018
Diabetes Mellitus: Is It Protective against Aneurysm? A Narrative Review
Patel K, Zafar MA, Ziganshin BA, Elefteriades JA. Diabetes Mellitus: Is It Protective against Aneurysm? A Narrative Review. Cardiology 2018, 141: 107-122. PMID: 30453299, DOI: 10.1159/000490373.Peer-Reviewed Original ResearchConceptsAbdominal aortic aneurysmAortic aneurysmDiabetic patientsAortic dissectionDipeptidyl peptidase-4 inhibitorsCommon antidiabetic medicationsPrevalence of TAAsPeptidase-4 inhibitorsAneurysm growth rateSmaller aneurysm diameterAortic wall stressRate of mortalityLow rupture ratesAntidiabetic medicationsAortic surgeryHospital stayDiabetic stateAortic growthAneurysm diameterAntidiabetic agentsDecreased lengthAneurysmsProtective roleRupture rateMatrix metalloproteinases
2017
Thoracic aortic aneurysm: unlocking the “silent killer” secrets
Saeyeldin AA, Velasquez CA, Mahmood SUB, Brownstein AJ, Zafar MA, Ziganshin BA, Elefteriades JA. Thoracic aortic aneurysm: unlocking the “silent killer” secrets. General Thoracic And Cardiovascular Surgery 2017, 67: 1-11. PMID: 29204794, DOI: 10.1007/s11748-017-0874-x.Peer-Reviewed Original ResearchConceptsAortic aneurysmAngiotensin receptor blockersFamilial patternBicuspid aortic valveAbdominal aortic aneurysmRisk of ruptureDifferent embryologic originsReceptor blockersBeta blockersType of repairThoracic aneurysmInflammatory disordersFemale sexSerum biomarkersAortic valveWorse outcomesEmbryologic originMedical treatmentEnzyme inhibitorsAneurysmsSilent killerIntracranial aneurysmsNatural historyOnly reliable methodPattern of inheritance